Retraction
The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells
Paper Information
Record ID:
56376
Author(s):
Journal:
Publication Date:
March 19, 2016
Retraction Date:
August 30, 2024
(1.2 year years ago)
Subjects:
Institutions:
- Department of Experimental Medicine, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy
- Department of Molecular Medicine, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy
- Department of Pharmacy, “G. D’Annunzio” University of Chieti-Pescara, Via dei Vestini 31, 66100, Chieti, Italy
Country:
🇮🇹 ItalyArticle Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (23)
23
Total Citations1
Post-Retraction(4.3%)
22
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
209
Days since retraction (latest)
From Motor Proteins to Oncogenic Factors: The Evolving Role of Kinesin Superfamily Proteins in Breast Cancer Development
Mohamed J. Saadh, Hanan Hassan Ahmed, Radhwan Abdul Kareem et al. (11 authors)
Molecular Biotechnology
Published: Mar 2025
209 days after retraction
The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside
Kai Zhao, Xiangyü Li, Yunxiang Feng et al. (5 authors)
Biomarker Research
Open Access
Published: Mar 2024
6 citations
6 citations
180 days before retraction
Selective synthesis of thiadiazolo-2H-chromen-2-ones and chromeno-thiadiazolo-pyrimidines under thermal conditions and microwave irradiation catalyzed by calixarene-based ionic liquid immobilized on magnetic nanoparticles
Akram Khalili, Iraj Mohammadpoor‐Baltork, Valiollah Mirkhani et al. (7 authors)
Journal of Molecular Liquids
Published: Jan 2024
1 citation
1 citation
218 days before retraction
Synthesis, molecular docking, and molecular dynamic simulation studies of new 1,3,4-thiadiazole derivatives as potential apoptosis inducers in A549 lung cancer cell line
Leyla Yurttaş, Asaf Evrim Evren, Huda AlChaib et al. (5 authors)
Journal of Biomolecular Structure and Dynamics
Published: Jan 2024
7 citations
7 citations
241 days before retraction
A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma
Tao Zhang, Jian Gu, Xinyi Wang et al. (9 authors)
Frontiers in Immunology
Open Access
Published: Mar 2023
2 citations
2 citations
547 days before retraction
Synthesis, crystal structure and evaluation of anticancer activities of some novel heterocyclic compounds based on thymol
Yassine Laamari, Abdoullah Bimoussa, Mourad Fawzi et al. (9 authors)
Journal of Molecular Structure
Open Access
Published: Jan 2023
18 citations
18 citations
605 days before retraction
Mechanism-based approaches of 1,3,4 thiadiazole scaffolds as potent enzyme inhibitors for cytotoxicity and antiviral activity
Davinder Kumar, Harsh Kumar, Virender Kumar et al. (7 authors)
Medicine in Drug Discovery
Open Access
Published: Dec 2022
27 citations
27 citations
625 days before retraction
Kinesin Eg5 Selective Inhibition by Newly Synthesized Molecules as an Alternative Approach to Counteract Breast Cancer Progression: An In Vitro Study
Alessia Ricci, Amelia Cataldi, Simone Carradori et al. (4 authors)
Biology
Open Access
Published: Oct 2022
4 citations
4 citations
698 days before retraction
The kinesin Eg5 inhibitor K858 exerts antiproliferative and proapoptotic effects and attenuates the invasive potential of head and neck squamous carcinoma cells
Alice Nicolai, Samanta Taurone, Simone Carradori et al. (7 authors)
Investigational New Drugs
Open Access
Published: Mar 2022
6 citations
6 citations
893 days before retraction
Kinesin Spindle Protein Inhibitors in Cancer: From High Throughput Screening to Novel Therapeutic Strategies
Rand Shahin, Salah Aljamal
Future Science OA
Open Access
Published: Feb 2022
39 citations
39 citations
921 days before retraction
Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer
Bruna C. Guido, Douglas Cardoso Brandão, Ana Luisa Augusto Barbosa et al. (11 authors)
Oncotarget
Open Access
Published: Aug 2021
5 citations
5 citations
1095 days before retraction
KIF15 upregulation promotes leiomyosarcoma cell growth via promoting USP15-mediated DEK deubiquitylation
Weiming Ge, Yuxuan Chen, Yusheng Guo et al. (7 authors)
Biochemical and Biophysical Research Communications
Published: Jul 2021
7 citations
7 citations
1141 days before retraction
1,3,4-Thiadiazoline−coumarin hybrid compounds containing D-glucose/D-galactose moieties: Synthesis and evaluation of their antiproliferative activity
Vũ Ngọc Toán, Nguyễn Đình Thành, Tri Nguyen
Arabian Journal of Chemistry
Open Access
Published: Feb 2021
17 citations
17 citations
1300 days before retraction
Thiadiazole derivatives as anticancer agents
Monika Szeliga
Pharmacological Reports
Open Access
Published: Sep 2020
80 citations
80 citations
1457 days before retraction
Alkaloids isolated from Tropaeolum tuberosum with cytotoxic activity and apoptotic capacity in tumour cell lines
Luis Apaza Ticona, Julia Sebastián, Andreea Mădălina Șerban et al. (4 authors)
Phytochemistry
Open Access
Published: Jun 2020
9 citations
9 citations
1535 days before retraction
Kinesin Eg5 Targeting Inhibitors as a New Strategy for Gastric Adenocarcinoma Treatment
Guya Diletta Marconi, Simone Carradori, Alessia Ricci et al. (6 authors)
Molecules
Open Access
Published: Oct 2019
20 citations
20 citations
1765 days before retraction
KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer
Juan Zhou, Weirong Chen, Lichao Yang et al. (8 authors)
Cancer Research and Treatment
Open Access
Published: Dec 2018
62 citations
62 citations
2073 days before retraction
Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors
Sandeep K. Talapatra, Chuin Lean Tham, Paolo Guglielmi et al. (8 authors)
European Journal of Medicinal Chemistry
Open Access
Published: Jul 2018
25 citations
25 citations
2249 days before retraction
Growth arrest and apoptosis induced by kinesin Eg5 inhibitor K858 and by its 1,3,4-thiadiazoline analogue in tumor cells
Sabrina Giantulli, Francesca De Iuliis, Ludovica Taglieri et al. (8 authors)
Anti-Cancer Drugs
Published: May 2018
9 citations
9 citations
2305 days before retraction
Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics
Anton Lucanus, George W. Yip
Oncogene
Published: Oct 2017
113 citations
113 citations
2503 days before retraction
The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells
Ludovica Taglieri, G Rubinacci, A. M. Giuffrida et al. (5 authors)
Investigational New Drugs
Published: Sep 2017
19 citations
19 citations
2526 days before retraction
Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells
Ludovica Taglieri, Francesca De Iuliis, A. M. Giuffrida et al. (6 authors)
Oncology Letters
Open Access
Published: Jul 2017
13 citations
13 citations
2600 days before retraction
Thiadiazole inhibitors: a patent review
Kamal M. Dawood, Thoraya A. Farghaly
Expert Opinion on Therapeutic Patents
Published: Dec 2016
83 citations
83 citations
2811 days before retraction
Quick Stats
Total Citations:
23
Years Since Retraction:
1.2 year
Open Access:
Yes
Last Checked:
Jul 24, 2025